Sarah Kalil Net Worth & Insider Trades
Sarah Kalil - Chief Operating Officer, T2 Biosystems, Inc
What is Sarah Kalil's Net Worth?
The current estimated net worth of T2 Biosystems, Inc's Chief Operating Officer, Sarah Kalil, is estimated to be about $27.9K . Sarah Kalil owns about 61,500 units of T2 Biosystems, Inc common stock. In the last year at T2 Biosystems, Inc, Sarah Kalil has sold an estimated value of $0 worth.
What is Sarah Kalil's Past Insider Trading?
Sarah Kalil's largest purchase order was 5,000 units , worth over $55K on April 30, 2015. In total, Sarah Kalil has made about 4 transactions over a year of their time at T2 Biosystems, Inc. Sarah Kalil usually trades in March, with the busiest year in 2015.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sarah Kalil
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Sarah Kalil's' Mailing Address?
- Mailing address is T2 Biosystems, Inc. 101 Hartwell Ave Lexington MA 02421 MA
T2 Biosystems, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John Sperzel, | 2020 | $490,705 | - | - | $2,571,384 | $393,750 | $3,000 | $3,458,839 |
| John McDonough, | 2020 | $72,906 | - | $74,999 | - | - | $1,022,182 | $1,170,087 |
| John McDonough, | 2019 | $550,000 | - | $372,000 | $478,728 | $233,750 | $3,000 | $1,637,478 |
| Alec Barclay, | 2020 | $340,000 | - | $25,675 | $38,621 | $234,600 | $952 | $639,848 |
| Alec Barclay, | 2019 | $337,500 | $35,000 | $111,600 | $348,834 | $102,000 | $2,900 | $937,834 |
| Anthony Pare, | 2020 | $325,000 | - | $20,738 | $159,763 | $185,250 | $3,000 | $693,751 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm
What are T2 Biosystems, Inc's Past Insider Trades?
T2 Biosystems, Inc's most recent insider trade came on September 29, 2023 by CR Group Lp, Crg Partners Iii Lp, Crg Partners Iii Parallel Fund A Lp, Crg Partners Iii Cayman Unlev Aiv I Lp and Crg Partners Iii Cayman Lev Aiv I Lp who sold 13,130,147 units worth $2.27M . In the last 9 years, insiders at T2 Biosystems, Inc have sold an estimated value of $21.95M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer, David Elsbree, and Terrence Michael Gibbs, General Counsel .
T2 Biosystems, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||